Beyond pharmacy blog
All posts by Gustaf Duhs
Pfizer and Flynn Pharma fined £90m for excessive pricing — what are the implications?
Gustaf Duhs explains the ruling behind the Competition and Markets Authority’s £90m fine on Pfizer and Flynn Pharma’s excessive drug pricing.